Table 3.
Basal gene expression differences in untreated Bpifa1−/− mice
| Genes | Symbol | FC | P |
|---|---|---|---|
| Schlafen 4 | Slfn4 | −2.41 | 0.034 |
| Pyrin domain-containing 4 | Pydc4 | −2.05 | 0.010 |
| Plasminogen activator, urokinase | Plau | −1.77 | 0.015 |
| Interferon-induced transmembrane protein 6 | Ifitm6 | −1.66 | 0.022 |
| Z-DNA binding protein 1 | Zbp1 | −1.61 | 0.005 |
| Apolipoprotein L 9a | Apol9a | −1.61 | 0.005 |
| Pyrin domain containing 3 | Pydc3 | −1.54 | 0.008 |
| Chemokine (C-C motif) receptor 2 | Ccr2 | −1.50 | 0.049 |
| Major facilitator superfamily domain-containing 2A | Mfsd2a | 1.64 | 0.023 |
| Fatty acid-binding protein-12 | Fabp12 | 4.79 | 0.039 |
Whole-lung microarray results showing differential gene expression in untreated wild-type (WT) and Bpifa1−/−, BPI fold-containing group A member 1 deficient (Bpifa1−/−) mice [2-way ANOVA, false discovery rate < 0.05; fold change (FC) >1.5]. Negative FC values denote lower gene expression relative to WT.